Adamas製藥 ADMS 深 滬
已收盤 11-24 16:00:00 美东时间
8.22
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 8.22
- 總市值 3.76亿
- 52周最高 9.15
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.02
- 委 比 0.00%
- 總股本 4578.70万
- 歷史最高 44.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.90
- 每 手 1
- 風險率 0.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多药闻头条丨Moderna急了！敦促FDA授权加强针，赛生新抗生素拟上市
欧康维视自研干眼症药首度获批临床；歌礼慢性乙肝药将公布二期临床数据；阿斯利康在华设立全球研发中心>>
2021-10-13 13:37
JMP证券将Adamas制药评级下调至市场表现
JMP Securities analyst Jason Butler downgrades Adamas Pharmaceuticals (NASDAQ:A...
2021-10-12 06:52
JMP Securities Downgrades Adamas Pharmaceuticals to Market Perform
JMP Securities analyst Jason Butler downgrades Adamas Pharmaceuticals (NASDAQ:A...
2021-10-12 06:52
Piper Sandler将Adamas PharmPharmticals评级下调至中性，将目标价上调至8美元
Piper Sandler analyst David Amsellem downgrades Adamas Pharmaceuticals (NASDAQ:...
2021-10-12 06:48
Adamas to Present at Upcoming Healthcare Conferences
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing ...
2021-02-17 21:06
Adamas to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
EMERYVILLE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, I...
2020-07-23 20:02
Why Adamas Pharmaceuticals Is Trading Lower Today
Adamas Pharmaceuticals (NASDAQ: ADMS) shares are trading lower on Thursday afte...
2020-06-18 11:12
New CEO at Adamas Pharma
Adamas Pharmaceuticals (NASDAQ:ADMS) appointsNeil McFarlaneas CEO a...
2019-09-13 19:40
Mitsubishi Tanabe launches late-stage study in U.S. for continuous Parkinson's therapy
Mitsubishi Tanabe launches late-stage study in U.S. for continuous Parkinson's therapy
2019-08-28 22:26
Adamas Pharmaceuticals: A Second Inning In Play
ADMS had a very strong performance in the run-up to its 2017 approval of GOCOVR...
2019-08-27 03:03
